Brain Tumor Treatments: Chemotherapy
Sponsored By
Angiochem breast mets to brain trial
Please Click On The Above Banner For More Details
Braintumor Website

Search Term: Chemotherapy
Please scroll down past the trials to see pages on this site about this topic!

  Previous 25 Showing Treatment 26 to 50 of 854 Next 25 Location Last Updated
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Seattle, WA USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Great Neck & Commack, NY USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Sacramento, CA USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Peoria, IL USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Kansas City, MO USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma St. Louis, MO USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma White Plains, NY USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Cincinnati, OH USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Washington, DC USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Manhasset, NY USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Miami Beach, FL USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Hackensack, NJ USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Cincinnati, OH USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Providence, RI USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Chicago, IL USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Chicago, IL USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Chicago, IL USA 11/29/2014
Details A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma Chicago, IL USA 11/29/2014
Details Protocol H9H-MC-JBAL- A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate plus Lomustine Therapy compared to Lomustine Monotherapy in Patients with Recurrent Glioblastoma Chicago, IL USA 11/29/2014
Details mpkssjsi Calgary, Alberta, NY Canada 06/01/2013
Details Protocol H9H-MC-JBAL- A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate plus Lomustine Therapy compared to Lomustine Monotherapy in Patients with Recurrent Glioblastoma Cincinnati, OH USA 06/01/2013
Details An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma(The “ACT IV” Study) San Francisco, CA USA 10/08/2012
Details Protocol H9H-MC-JBAI - Phase 1b/2a Study Combining LY2157299 with Standard Temozolomide-based Radiochemotherapy in Patients with Newly Diagnosed Malignant Glioma San Francisco, CA USA 10/08/2012
Details A Phase I Dose Escalation Study of Hypofractionated Stereotactic Radiotherapy with Bevacizumab in the Treatment of Recurrent Malignant Glioma San Francisco, CA USA 10/08/2012
Details Protocol H9H-MC-JBAL- A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate plus Lomustine Therapy compared to Lomustine Monotherapy in Patients with Recurrent Glioblastoma San Francisco, CA USA 10/08/2012

(Relevance) Page Title - click title to go to the page!

  (0.9115)   Temodar: References
  (0.8912)   Medulloblastoma
  (0.8658)   Trials by NCT number
  (0.8510)   Brain Tumor Treatments: Chemotherapy
  (0.8510)   Trials without an NCT number
  (0.8351)   Advanced Search
  (0.8169)   High Dose Tamoxifen For Brain Tumors
  (0.8169)   Treatment Options For Glioblastomas
  (0.8169)   PCV For Brain Tumors: Abstracts
  (0.8169)   Recently Updated Treatments
  (0.7967)   Brain Tumor Treatments: China PR
  (0.7967)   Brain Tumor Treatments: Canada
  (0.7967)   Temozolomide Update
  (0.7967)   Temozolomide Update
  (0.7967)   Temozolomide: Press Release
  (0.7967)   What Are Clinical Trials
  (0.7967)   Rainbow Memorial Video Archives
  (0.7967)   Noteworthy Treatments For Brain Tumors
  (0.7967)   High Dose Tamoxifen For Brain Tumors
  (0.7967)   Brain Tumor Survivor Stories
  (0.7967)   Brain Tumor Survivor Stories
  (0.7967)   Brain Tumor Survivor Stories
  (0.7967)   Brain Tumor / Brain Cancer Symptoms, Diagnoses, Treatments and Clinical Trials
  (0.7967)   Brain Tumor / Brain Cancer Symptoms, Diagnoses, Treatments and Clinical Trials
  (0.7967)   Site Map
  (0.7967)   Search for a Specific Trial or Treatment
  (0.7967)   Chemosensitivity For Oligodendrogliomas
  (0.7967)   Noteworthy Treatments For Brain Tumors
  (0.7967)   Virtualtrials Newsletter Index
  (0.7967)   Virtualtrials Newsletter
  (0.7967)   Search for a Specific Trial or Treatment
  (0.7967)   Emerging Med Trials Matcher
  (0.7967)   Brain Metastases (Mets, Secondary Brain Tumors)
  (0.7967)   Brain Tumor BookList
  (0.7967)   Brain Tumor BookList
  (0.7967)   Brain Tumor Treatments: Australia
  (0.7742)   Class Action Fundraiser
  (0.7742)   Brain Tumor Chat Room
  (0.7742)   Brain tumor Chat room registration
  (0.7742)   Problem Report Received
  (0.7742)   Brain Tumor Chat Room Problem
  (0.7742)   Brain Tumor Community Chat Room
  (0.7742)   Brain Tumor Chat Room
  (0.7742)   Brain Tumor Chat Room
  (0.7742)   Brain Tumor Chat room
  (0.7742)   Brain Tumor Chat room
  (0.7742)   Changes to the website
  (0.7742)   Brain Tumor Treatments: California
  (0.7742)   Mathametical modeling of brain tumor treatments
  (0.7742)   Braintmr List Options
  (0.7742)   Pacific Northwest Brain Tumor List
  (0.7742)   Pacific Northwest Braintumor List
  (0.7742)   Brain Tumor Centers
  (0.7742)   Brain Faith List
  (0.7742)   Braintumor Faith List
  (0.7742)   Online Support Groups
  (0.7742)   Brainstem Glioma List
  (0.7742)   Common Brain Tumor Terms
  (0.7742)   Brain Tumor Virtual Trial List
  (0.7742)   Brain Tumor Virtual Trial List
  (0.7742)   Temodar: Review
  (0.7742)   Temodar Paper: Print
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide Update
  (0.7742)   Brain Tumor News: Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma.
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide: Patient Instructions
  (0.7742)   Temozolomide (Temodar®)
  (0.7742)   Letter Writting Campaign
  (0.7742)   Temozolomide Dose
  (0.7742)   Brain Tumor Guide
  (0.7742)   Dr. Hamilton Interview
  (0.7742)   Gliadel® Doctors: Alphabetical
  (0.7742)   Gleevec For Brain Tumors
  (0.7742)   Gleevec Trials For Brain Tumors
  (0.7742)   Brain Tumor Treatments: Wyoming
  (0.7742)   Brain Tumor Treatments: West Virginia
  (0.7742)   Wristbands
  (0.7742)   Long Island Wrecks & Obstructions
  (0.7742)   Long Island Wrecks & Obstructions
  (0.7742)   Treatment Options for Glioblastomas
  (0.7742)   Brain Tumor Treatments: Wisconsin
  (0.7742)   Brain Tumor Treatments: Washington
  (0.7742)   Virtual Trial Map
  (0.7742)   Virtual Trial Map
  (0.7742)   Brain Tumor Treatments: Vermont
  (0.7742)   Brain Tumor Treatments: VP-16
  (0.7742)   Volumetric Stereotactic Procedures
  (0.7742)   Virtual Trial: An internet-based brain tumor registry





Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2014 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites